Diametric Capital’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,031
| Closed | -$210K | – | 331 |
|
|
2025
Q1 | $210K | Buy |
+7,031
| New | +$210K | 0.25% | 134 |
|
|
2023
Q1 | – | Sell |
-13,370
| Closed | -$310K | – | 370 |
|
|
2022
Q4 | $310K | Sell |
13,370
-16,126
| -55% | -$374K | 0.15% | 198 |
|
|
2022
Q3 | $473K | Buy |
+29,496
| New | +$473K | 0.24% | 142 |
|
|
2022
Q1 | – | Sell |
-18,064
| Closed | -$537K | – | 271 |
|
|
2021
Q4 | $537K | Buy |
+18,064
| New | +$537K | 0.41% | 55 |
|
|
2021
Q2 | – | Sell |
-13,519
| Closed | -$320K | – | 147 |
|
|
2021
Q1 | $320K | Sell |
13,519
-8,846
| -40% | -$209K | 0.24% | 95 |
|
|
2020
Q4 | $448K | Buy |
+22,365
| New | +$448K | 0.36% | 85 |
|
|
2020
Q3 | – | Sell |
-51,634
| Closed | -$904K | – | 136 |
|
|
2020
Q2 | $904K | Sell |
51,634
-4,265
| -8% | -$74.7K | 0.69% | 61 |
|
|
2020
Q1 | $913K | Buy |
+55,899
| New | +$913K | 1.11% | 35 |
|